Search - tctmd.com

Displaying 381 - 400 of 487

Sort: Relevancy | Date

Impact of Paclitaxel Formulation on Drug Transfer, Tissue Pharmacokinetics, and Biological Activity

Presentation TCT 2012

Impact of Paclitaxel Formulation on Drug Transfer, Tissue Pharmacokinetics, and Biological Activity

Presenter: Juan Granada

October 25, 2012

DEBATE-BTK: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty in Diabetic Patients with Critical Limb Ischemia Undergoing Angioplasty of Below-the-Knee...

Presentation TCT 2012

DEBATE-BTK: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty in Diabetic Patients with Critical Limb Ischemia Undergoing Angioplasty of Below-the-Knee...

Presenter: Francesco Liistro

October 25, 2012

TCT-70. Comparison of Efficacy and Safety Between Sirolimus, Paclitaxel, Everolimus-eluting Stent and SeQuent™ Please, a Drug-eluting Balloon on the Outcome of Patients with...

Presentation TCT 2012

TCT-70. Comparison of Efficacy and Safety Between Sirolimus, Paclitaxel, Everolimus-eluting Stent and SeQuent™ Please, a Drug-eluting Balloon on the Outcome of Patients with...

Presenter: Sunao Nakamura

October 23, 2012

TCT-69. PEPCAD-DES: A Randomized, Multicenter, Single Blinded Trial Comparing Paclitaxel Coated Balloon Angioplasty with Plain Balloon Angioplasty in Drug-eluting-stent...

Presentation TCT 2012

TCT-69. PEPCAD-DES: A Randomized, Multicenter, Single Blinded Trial Comparing Paclitaxel Coated Balloon Angioplasty with Plain Balloon Angioplasty in Drug-eluting-stent...

Presenter: Harald Rittger

October 23, 2012

TCT-585: Six-Month Results of the BIOLUX P-I First-in-Man Study Comparing a Paclitaxel-Releasing Balloon Catheter vs. an Uncoated Balloon Catheter in Femoropopliteal Lesions

Presentation TCT 2012

TCT-585: Six-Month Results of the BIOLUX P-I First-in-Man Study Comparing a Paclitaxel-Releasing Balloon Catheter vs. an Uncoated Balloon Catheter in Femoropopliteal Lesions

Presenter: Dierk Scheinert

October 23, 2012

TCT-38. Two-year Clinical Data of Cohort 1 and Multi-modality Imaging Results Up to 1-year Follow-up of the BIOSOLVE-I Study with the Paclitaxel-eluting Bioabsorbable...

Presentation TCT 2012

TCT-38. Two-year Clinical Data of Cohort 1 and Multi-modality Imaging Results Up to 1-year Follow-up of the BIOSOLVE-I Study with the Paclitaxel-eluting Bioabsorbable...

Presenter: Michael Haude

October 23, 2012

J-DESSERT: A Prospective, Randomized Trial of Paclitaxel-Eluting vs. Sirolimus-Eluting Stents in Patients with and without Diabetes

Presentation TCT 2012

J-DESSERT: A Prospective, Randomized Trial of Paclitaxel-Eluting vs. Sirolimus-Eluting Stents in Patients with and without Diabetes

Presenter: Masato Nakamura

October 22, 2012

DEBATE-SFA: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty Prior to Nitinol Stenting in Patients with SFA and Popliteal Lesions

Presentation TCT 2012

DEBATE-SFA: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty Prior to Nitinol Stenting in Patients with SFA and Popliteal Lesions

Presenter: Francesco Liistro

October 22, 2012

News Industry News

Vascular Nanotransfer Technologies (“VNT”) reports in vivo results for its paclitaxel nano-carrier based drug coated balloon (DCB) technology

October 19, 2012

News Daily News

Los Balones liberadores de Fármacos arrojan Resultados Positivos en el Tratamiento de la Reestenosis intra stent

October 05, 2012

News Daily News

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

October 05, 2012

News Daily News

Stent Fractures Persist Among Newer-Generation Devices

October 02, 2012

News Daily News

Las Fracturas del Stent Persisten en los Dispositivos de Nueva Generación

October 02, 2012

News Conference News ESC 2012

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

August 29, 2012

News Daily News

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

August 16, 2012

News Daily News

Meta Análisis: Los SLF son Aceptables aunque No están Exentos de Problemas en la Enfermedad del Tronco Coronario Izdo

August 16, 2012

News Daily News

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

August 07, 2012

News Daily News

Meta Análisis: El Balón Recubierto de Paclitaxel Reduce la RLD en la Enfermedad Femoropoplítea

August 07, 2012

Paclitaxel-Coated vs. Uncoated Balloon Angioplasty Reduces TLR in Femoropopliteal Disease

Presentation

Paclitaxel-Coated vs. Uncoated Balloon Angioplasty Reduces TLR in Femoropopliteal Disease

Presenter: S. Cassese

August 06, 2012

News Daily News

Se Publica el RESET: Eficacia y Seguridad Parecidas con SLE y SLS al cabo de 1 Año

July 30, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.